Genetic engineering is moving from the lab bench into clinics, farms, and even family planning decisions, promising to change how we prevent disease, age, and define human potential. The same tools ...
Despite the regulatory and funding roadblocks, Murray and fellow researcher Elizabeth Maga continue to work on a line of genetically engineered goats, which carry a human gene that produces elevated ...
(Reuters) - Scientists in China have manipulated embryonic stem cells to create laboratory mice with two male parents that managed to live to adulthood - though with significant developmental ...
Drexel University sophomore Jessica Wu chose electrical engineering to satisfy her curiosity about everyday technology. "I wanted to know how things like my phone and TVs work, and how electricity can ...
'Return' of the dire wolf is an impressive feat of genetic engineering, not a reversal of extinction
Dallas-based biotech company Colossal has announced the birth of three pups bearing the DNA signatures of dire wolves, an iconic predator last seen roaming North America over 10,000 years ago. With ...
Morning Overview on MSN
Researchers develop DNA encryption to secure engineered cells from tampering
In April 2026, a team of bioengineers at the Georgia Institute of Technology unveiled a genetic security system that works ...
DNA nanotechnology is an interdisciplinary field that exploits the inherent base-pairing rules of DNA to design and assemble nanoscale structures with high precision. These engineered constructs have ...
Gene editing is now reaching the mainstream, ushering in a new era of genetic manipulation. Traditionally, inserting or deleting entire genes, regulating their expression, and altering specific ...
Despite these advances, the synthesis of DNA nanostructures has remained a largely manual and time-consuming process. Traditional approaches often require the precise mixing of hundreds of unique DNA ...
Colossal Secures $60M Series A Funding To Advance Genetic Engineering and De-extinction Technologies
DALLAS--(BUSINESS WIRE)--Colossal Biosciences, a breakthrough biosciences and genetic engineering company, announced an oversubscribed $60M Series A financing led by Thomas Tull and At One Ventures ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results